Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

(2018) Jean-Charles Soria et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Features of Precocious, Synchronous, and Metachronous Brain Metastases and the Role of Tumor Resection

(2018) Ichiyo Shibahara et al.   World Neurosurgery

Ablative therapy in oligometastatic non-small cell lung cancer—an editorial on recent evidence

(2018) Mark Niglas et al.   Journal of Thoracic Disease

Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer

(2018) Andrew Song et al.   Journal of Thoracic Disease

Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases

(2018) Kaiyan Chen et al.   LUNG CANCER

Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer

(2017) Chul Kim et al.   Journal of Thoracic Oncology

Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial

(2017) Alice T Shaw et al.   LANCET ONCOLOGY

The Effects of smoking status and smoking history on patients with brain metastases from lung cancer

(2017) Rachel F. Shenker et al.   Cancer Medicine

Estimating Survival in Patients With Lung Cancer and Brain Metastases

(2017) Paul W. Sperduto et al.   JAMA Oncology

A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients

(2016) Fanrong Zhang et al.   ANNALS OF SURGICAL ONCOLOGY

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer

(2016) Jochen Fleckenstein et al.   BMC CANCER

First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

(2016) Martin Schuler et al.   Journal of Thoracic Oncology

An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

(2014) Allison B. Ashworth et al.   Clinical Lung Cancer

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study

(2014) Shirish M Gadgeel et al.   LANCET ONCOLOGY

The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support

(2014) Graham W Warren et al.   LANCET ONCOLOGY

Symptom Management in Patients With Lung Cancer

(2013) Michael J. Simoff et al.   CHEST

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

(2011) Paul W. Sperduto et al.   JOURNAL OF CLINICAL ONCOLOGY